AusBiotech CEO Lorraine Chiroiu says the change to the R&D Tax Incentive is a "hidden detail" in the bill that will impact "vulnerable enterprises" focused on developing new therapies, devices, vaccines and diagnostics. …
Latest Video
New Stories
-
Grattan proposes PBS savings for dental scheme
March 19, 2019 - - Latest News -
TGA: No impact on medicine supply with no-deal 'Brexit'
March 19, 2019 - - Latest News -
STA welcomes breast cancer approval
March 19, 2019 - - Latest News -
New listings for April as caretaker approaches
March 18, 2019 - -
Therapeutic groups may not deliver like they once did
March 18, 2019 - - Latest News -
Who is thinking about the future?
March 18, 2019 - - Latest News -
Labor attitude on SPAs probably more important than Greg Hunt's
March 18, 2019 - - Latest News